1,https://www.reuters.com/article/brief-volition-files-patent-for-nuq-covi/brief-volition-files-patent-for-nu-q-covid-19-triage-test-and-commences-proof-of-concept-studies-idUSFWN2CB0LX,2020-04-23T12:34:35Z,BRIEF-Volition Files Patent For Nu.Q(Tm) Covid-19 Triage Test And Commences Proof Of Concept Studies,April 23 (Reuters) - VolitionRX Ltd:,* VOLITION FILES PATENT FOR NU.Q(TM) COVID-19 TRIAGE TEST AND COMMENCES PROOF OF CONCEPT STUDIES,* VOLITIONRX -WORKING WITH COLLABORATORS TO INVESTIGATE IF EXISTING NU.Q(TM) EPIGENETIC ASSAYS CAN PREDICT WHICH PATIENTS WITH COVID-19 ARE MOST AT RISK Source text for Eikon: Further company coverage:
2,https://www.reuters.com/article/brief-nu-skin-enterprises-q1-earnings-pe/brief-nu-skin-enterprises-q1-earnings-per-share-0-64-idUSASC09XX2,2018-04-26T20:56:38Z,BRIEF-Nu Skin Enterprises Q1 Earnings Per Share $0.64,April 26 (Reuters) - NU Skin Enterprises Inc:,* NU SKIN ENTERPRISES REPORTS STRONG FIRST-QUARTER RESULTS AND INCREASES ANNUAL GUIDANCE,* Q1 EARNINGS PER SHARE VIEW $0.69 -- THOMSON REUTERS I/B/E/S,* FY2018 EARNINGS PER SHARE VIEW $3.61 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:
3,https://www.reuters.com/article/brief-nu-skin-enterprises-enters-into-a/brief-nu-skin-enterprises-enters-into-a-credit-agreement-that-provides-for-a-400-million-term-loan-facility-idUSFWN1S013Z,2018-04-23T20:28:49Z,BRIEF-Nu Skin Enterprises Enters Into A Credit Agreement That Provides For A $400 Million Term Loan Facility,April 23 (Reuters) - NU Skin Enterprises Inc:,"* NU SKIN ENTERPRISES SAYS ON APRIL 18, 2018 CO ENTERED INTO A CREDIT AGREEMENT THAT PROVIDES FOR A $400 MILLION TERM LOAN FACILITY - SEC FILING",* NU SKIN ENTERPRISES INC - CREDIT AGREEMENT ALSO PROVIDES FOR A $350 MILLION REVOLVING CREDIT FACILITY EACH WITH A TERM OF FIVE YEARS Source text for Eikon: (bit.ly/2HmJK6B) Further company coverage:
